lifestyle.celebhomes.net
Home
Sample Page
Author:
Spago Nanomedical
Spago Nanomedical Interim Report January-March 2026
May 7, 2026
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
Spago Nanomedical Continues Recruitment in The Phase I/IIa Tumorad-01 Study Following Positive DMC Recommendation
March 17, 2026
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
Spago Nanomedical Year-End Report January-December, 2025
February 5, 2026
Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2026
December 8, 2025